Sign In
Buy ATRC
$37.76
-2.39 (-5.95%)
At Close: Jul 31, 2026
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
06:10pm, Tuesday, 29'th Apr 2025
AtriCure (ATRC) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.25 per share a year ago.
AtriCure Reports First Quarter 2025 Financial Results
04:01pm, Tuesday, 29'th Apr 2025
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-op
AtriCure to Announce First Quarter 2025 Financial Results
08:00am, Tuesday, 08'th Apr 2025
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-o
AtriCure to Host Analyst & Investor Day on March 26, 2025
08:00am, Wednesday, 12'th Mar 2025
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-o
AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know
01:01pm, Thursday, 13'th Feb 2025
AtriCure (ATRC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AtriCure, Inc. (ATRC) Q4 2024 Earnings Call Transcript
10:46pm, Wednesday, 12'th Feb 2025
AtriCure, Inc. (NASDAQ:ATRC ) Q4 2024 Earnings Conference Call February 12, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief Executive Office
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings
06:31pm, Wednesday, 12'th Feb 2025
While the top- and bottom-line numbers for AtriCure (ATRC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compa
AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates
06:16pm, Wednesday, 12'th Feb 2025
AtriCure (ATRC) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.21 per share a year ago.
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
04:01pm, Wednesday, 12'th Feb 2025
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-op
Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS
10:20am, Tuesday, 11'th Feb 2025
Besides Wall Street's top -and-bottom-line estimates for AtriCure (ATRC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the q
Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know
11:05am, Wednesday, 05'th Feb 2025
AtriCure (ATRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results
08:00am, Wednesday, 22'nd Jan 2025
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-o
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
08:00am, Monday, 23'rd Dec 2024
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-o
AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript
11:53pm, Tuesday, 29'th Oct 2024
AtriCure, Inc. (NASDAQ:ATRC ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief Executive Officer
AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Tuesday, 29'th Oct 2024
While the top- and bottom-line numbers for AtriCure (ATRC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics comp
